Femke S. Van Der Meer
Nieuwegein, UT 3430EM, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High-resolution cryo-EM structure of integrin αIIbβ3 bound to disease-causing maternal HPA-1a antibody that blocks integrin activation.
Journal: Science advances
Published: July 17, 2026
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study.
Journal: Journal for immunotherapy of cancer
Published: June 15, 2026
C3G deregulation uncovers a dual role in B-cell lymphoma: tumor suppression and enhanced metastasis via Rap1 and Rac2 signaling.
Journal: Cell communication and signaling : CCS
Published: June 18, 2025
Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy.
Journal: Genes
Published: December 08, 2022
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.
Journal: Journal of personalized medicine
Published: October 19, 2021
The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients.
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 28, 2021
Feasibility of Concomitant Chemoradiotherapy in Daily Practice for Patients with NSCLC Stage III.
Journal: Anticancer research
Published: June 29, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026